MDM2 in breast cancer

被引：15
作者：
Masakazu Toi
Shigehira Saji
Akio Suzuki
Yutaka Yamamoto
Takeshi Tominaga
机构：
[1] Tokyo Metropolitan Komagome Hospital,Department of Surgery
来源：
Breast Cancer | 1997年 / 4卷 / 4期
关键词：
MDM2; Breast cancer; Drug resistance;
D O I：
10.1007/BF02966519
中图分类号：
学科分类号：
摘要：
TheMDM2 protein, an oncogene product, is known to act by suppressing p53 function. Although gene amplification ofMDM2 was frequently detected in human sarcomas, it was uncommon in the majority of epithelial tumors including breast cancer. However, recent reports have demonstrated that its translational activity is enhanced in a variety of carcinomas. In this report, we summarized the implications ofMDM2 overexpression in human breast cancer from the literature as well as our preliminary results.
引用
收藏
页码：264 / 268
页数：4
相关论文
共 128 条
[61]  
Furihata M(undefined)MDM2 protein confers the resistance of a human glioblastoma cell line to cisplatin-induced apoptosis undefined undefined undefined-undefined
[62]  
Ohtsuki Y(undefined)The expression of MDM2 and p53 protein in breast carcinoma undefined undefined undefined-undefined
[63]  
Girod SC(undefined)Immunochemical analysis of the interaction of p53 with MDM2; Fine mapping of the MDM2 binding site on p53 using synthetic peptides undefined undefined undefined-undefined
[64]  
Cesarz D(undefined)Sequence-specific DNA binding by p53; Identification of target sites and lack of binding to p53-MDM2 complexes undefined undefined undefined-undefined
[65]  
Fischer U(undefined)undefined undefined undefined undefined-undefined
[66]  
Landers JE(undefined)undefined undefined undefined undefined-undefined
[67]  
Haines DS(undefined)undefined undefined undefined undefined-undefined
[68]  
Strauss III JF,(undefined)undefined undefined undefined undefined-undefined
[69]  
Hunter SB(undefined)undefined undefined undefined undefined-undefined
[70]  
Abbott K(undefined)undefined undefined undefined undefined-undefined
234567891011